FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eddie Reed

Research Profile

Disorders

Anatomy

Tumor Cell Line

Chemicals & Drugs

Physiology

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Qingdi Quentin Li; Eddie Reed; Gangduo Wang; Lan Huang; Christopher F Cuff
Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy.
Jinshun Zhao; Qingdi Q Li; Baobo Zou; Gangduo Wang; Xiping Li; Jee Eun Kim; Christopher F Cuff; Lan Huang; Eddie Reed; Kevin Gardner
In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma.
Timothy Wiltshire; Jamie Senft; Yutian Wang; Gregory W Konat; Sharon L Wenger; Eddie Reed; Weixin Wang
BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eddie Reed (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Qingdi Quentin Li; Eddie Reed; Gangduo Wang; Lan Huang; Christopher F Cuff
Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy.
Basic & clinical pharmacology & toxicology 2010;107(5):868-76.
2007: Jinshun Zhao; Qingdi Q Li; Baobo Zou; Gangduo Wang; Xiping Li; Jee Eun Kim; Christopher F Cuff; Lan Huang; Eddie Reed; Kevin Gardner
In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma.
International journal of oncology 2007;31(2):241-52.
2007: Timothy Wiltshire; Jamie Senft; Yutian Wang; Gregory W Konat; Sharon L Wenger; Eddie Reed; Weixin Wang
BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven.
Molecular pharmacology 2007;71(4):1051-60.
2007: Yutian Wang; Timothy Wiltshire; Jamie Senft; Eddie Reed; Weixin Wang
Irofulven induces replication-dependent CHK2 activation related to p53 status.
Biochemical pharmacology 2007;73(4):469-80.
2006: Yutian Wang; Timothy Wiltshire; Jamie Senft; Sharon L Wenger; Eddie Reed; Weixin Wang
Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven.
Molecular cancer therapeutics 2006;5(12):3153-61.
2006: Xiaobing Liang; Eddie Reed; Jing Jie Yu
Protein phosphatase 2A interacts with Chk2 and regulates phosphorylation at Thr-68 after cisplatin treatment of human ovarian cancer cells.
International journal of molecular medicine 2006;17(5):703-8.
2006: Qing-Wu Yan; Eddie Reed; Xiao-Song Zhong; Keith Thornton; Yi Guo; Jing Jie Yu
MZF1 possesses a repressively regulatory function in ERCC1 expression.
Biochemical pharmacology 2006;71(6):761-71.
2005: X Li; G Wang; J Zhao; H Ding; C Cunningham; F Chen; Daniel C Flynn; Eddie Reed; Qingdi Q Li
Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase.
Cellular and molecular life sciences : CMLS 2005;62(7-8):894-904.
2005: G Wang; X Li; F Huang; J Zhao; H Ding; C Cunningham; J E Coad; Daniel C Flynn; Eddie Reed; Qingdi Q Li
Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death.
Cellular and molecular life sciences : CMLS 2005;62(7-8):881-93.
2005: Peilin Zhang; Weiyi Gao; Hongli Li; Eddie Reed; Fei Chen
Inducible degradation of checkpoint kinase 2 links to cisplatin-induced resistance in ovarian cancer cells.
Biochemical and biophysical research communications 2005;328(2):567-72.
2005: Jing Fang; Chang Xia; Zongxian Cao; Jenny Z Zheng; Eddie Reed; Bing-Hua Jiang
Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(3):342-53.
2004: Ramin Altaha; Xiaobing Liang; Jing Jie Yu; Eddie Reed
Excision repair cross complementing-group 1: gene expression and platinum resistance.
International journal of molecular medicine 2004;14(6):959-70.
2004: Xiao-Song Zhong; Jenny Z Zheng; Eddie Reed; Bing-Hua Jiang
SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
Biochemical and biophysical research communications 2004;324(2):471-80.
2004: Gangduo Wang; Eddie Reed; Qingdi Q Li
Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review).
Oncology reports 2004;12(5):955-65.
2004: Tiyuan Li; Yuping Song; Xiaobing Liang; Ying Guo; Eddie Reed; Jing Jie Yu
Confirmation of 42-bp deletion within the ERCC1 5' UTR.
International journal of oncology 2004;25(4):1105-11.
2004: Jian Wang; Timothy Wiltshire; Yutian Wang; Carmenza Mikell; Julian Burks; Cynthia Cunningham; Emily S Van Laar; Stephen J Waters; Eddie Reed; Weixin Wang
ATM-dependent CHK2 activation induced by anticancer agent, irofulven.
The Journal of biological chemistry 2004;279(38):39584-92.
2004: Xiaosong Zhong; Xiping Li; Gangduo Wang; Yunfeng Zhu; Guodong Hu; Jinshun Zhao; Cheryl Neace; Hong Ding; Eddie Reed; Qingdi Q Li
Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells.
International journal of oncology 2004;25(2):445-51.
2004: Jing Fang; Zongxian Cao; Yi Charlie Chen; Eddie Reed; Bing-Hua Jiang
9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells.
Molecular pharmacology 2004;66(1):178-86.
2004: Gangduo Wang; Eddie Reed; Qingdi Q Li
Apoptosis in prostate cancer: progressive and therapeutic implications (Review).
International journal of molecular medicine 2004;14(1):23-34.
2004: Peilin Zhang; Jie Wang; Weiyi Gao; Bao-Zhu Yuan; John Rogers; Eddie Reed
CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer.
Molecular cancer 2004;3():14.
2003: Eddie Reed; Jing Jie Yu; Antony Davies; James Gannon; Steven L Armentrout
Clear cell tumors have higher mRNA levels of ERCC1 and XPB than other histological types of epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5299-305.
2003: Ramin Altaha; Eddie Reed; Jame Abraham
Breast and ovarian cancer genetics and prevention.
The West Virginia medical journal 2003;99(5):187-91.
2003: Xiping Li; Xuyi Liu; Jie Wang; Zengli Wang; Wei Jiang; Eddie Reed; Yi Zhang; Yuanlin Liu; Qingdi Q Li
Effects of thalidomide on the expression of angiogenesis growth factors in human A549 lung adenocarcinoma cells.
International journal of molecular medicine 2003;11(6):785-90.
2003: Xiping Li; Xuyi Liu; Jie Wang; Zengli Wang; Wei Jiang; Eddie Reed; Yi Zhang; Yuanlin Liu; Qingdi Q Li
Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells.
Anticancer research 2003;23(3B):2481-7.
2003: X Zhong; Qingdi Q Li; Eddie Reed
SU5416 sensitizes ovarian cancer cells to cisplatin through inhibition of nucleotide excision repair.
Cellular and molecular life sciences : CMLS 2003;60(4):794-802.
2002: Ramin Altaha; Tito Fojo; Eddie Reed; Jame Abraham
Epothilones: a novel class of non-taxane microtubule-stabilizing agents.
Current pharmaceutical design 2002;8(19):1707-12.
2001: Jing Jie Yu; K Thornton; Y Guo; H Kotz; Eddie Reed
An ERCC1 splicing variant involving the 5'-UTR of the mRNA may have a transcriptional modulatory function.
Oncogene 2001;20(52):7694-8.